Main outcome events during follow-up in 707 patients with PMF
| . | No. . | % . | Rate % pt-yr . |
|---|---|---|---|
| Total deaths | 236 | 33 | 7.73 |
| Causes of mortality | |||
| Cardiovascular deaths* | 12 | 2 | 0.39 |
| Other | 201 | 28 | 6.58 |
| Unknown | 23 | 3 | 0.76 |
| Patients with nonfatal thrombotic events | 47 | 6.6 | 1.62 |
| AMI | 7 | 1.0 | 0.24 |
| Stroke-TIA | 11 | 1.6 | 0.38 |
| PAT | 7 | 1.0 | 0.24 |
| VTE | 22 | 3.1 | 0.76 |
| Patients with fatal and nonfatal thrombotic events | 51 | 7.2 | 1.75 |
| . | No. . | % . | Rate % pt-yr . |
|---|---|---|---|
| Total deaths | 236 | 33 | 7.73 |
| Causes of mortality | |||
| Cardiovascular deaths* | 12 | 2 | 0.39 |
| Other | 201 | 28 | 6.58 |
| Unknown | 23 | 3 | 0.76 |
| Patients with nonfatal thrombotic events | 47 | 6.6 | 1.62 |
| AMI | 7 | 1.0 | 0.24 |
| Stroke-TIA | 11 | 1.6 | 0.38 |
| PAT | 7 | 1.0 | 0.24 |
| VTE | 22 | 3.1 | 0.76 |
| Patients with fatal and nonfatal thrombotic events | 51 | 7.2 | 1.75 |
Years of follow-up, median (25th-75th percentiles): 2.92 (1.14-5.92).
PMF indicates primary myelofibrosis; AMI, acute myocardial infarction; TIA, transient ischemic attack; PAT, peripheral arterial thrombosis; and VTE, venous thrombosis emobolism.
The category of cardiovascular deaths included: pulmonary thromboembolism (n = 4), Budd-Chiari syndrome (n = 3), portal vein thrombosis (n = 2), stroke (n = 2), and sudden death (n = 1).